PRELUDE CAPITAL MANAGEMENT, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$11,361,000
+1462.7%
133,613
+551.0%
0.55%
+1272.5%
Q2 2020$727,000
+299.5%
20,523
+167.2%
0.04%
+233.3%
Q2 2018$182,000
+1554.5%
7,680
+997.1%
0.01%
+1100.0%
Q4 2017$11,000
+175.0%
700
+168.2%
0.00%
Q3 2017$4,0002610.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders